NASH company Genfit gains dual listing via NASDAQ offering

Liver disease company Genfit gained $1.85 to $22.17 on Wednesday after the company raised a combined $135.1 million via a NASDAQ

Read the full 218 word article

How to gain access

Continue reading with a
two-week free trial.